1. 2022-RA-464-ESGO A phase i dose escalation and expansion cohort trial of carboplatin and gemcitabine with the ATR inhibitor berzosertib in first or second recurrence platinum sensitive epithelial ovarian, peritoneal, and fallopian tube cancer. (20th October 2022) Authors: Wahner Hendrickson, Andrea E; Foster, Nathan; Corr, Bradley R; Duska, Linda; Markham, Merry J; Butler, Kristina; Girda, Eugenia; Miller, Rachel Ware; Arneson, Katherine; Gano, Katherine; Johnson, Janelle; Shapiro, Geoffrey; Rubinstein, Larry; Percy Ivy, S; Kohn, Elise; Adjei, Alex; Kaufmann, Scott Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 860 Targeting immunosuppressive macrophages overcomes PARP-inhibitor resistance in BRCA1-associated triple-negative breast cancer. (10th December 2020) Authors: Mehta, Anita; Cheney, Emily; Hartl, Christina; Pantelidou, Constantia; Oliwa, Madison; Castrillon, Jessica; Lin, Jia-Ren; Hurst, Katie; Taveira, Mateus de Oliveira; Johnson, Nathan; Oldham, William; Kalocsay, Marian; Berberich, Matthew; Boswell, Sarah; Kothari, Aditi; Johnson, Shawn; Dillon, Debo... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 860 Targeting immunosuppressive macrophages overcomes PARP-inhibitor resistance in BRCA1-associated triple-negative breast cancer. (9th November 2020) Authors: Mehta, Anita; Cheney, Emily; Hartl, Christina; Pantelidou, Constantia; Oliwa, Madison; Castrillon, Jessica; Lin, Jia-Ren; Hurst, Katie; Taveira, Mateus de Oliveira; Johnson, Nathan; Oldham, William; Kalocsay, Marian; Berberich, Matthew; Boswell, Sarah; Kothari, Aditi; Johnson, Shawn; Dillon, Debo... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A913 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Phase Ib Study to Evaluate the MEK Inhibitor Cobimetinib in Combination with the ERK1/2 Inhibitor GDC‐0994 in Patients with Advanced Solid Tumors. (28th May 2020) Authors: Weekes, Colin; Lockhart, Albert; LoRusso, Patricia; Murray, Elaine; Park, Erica; Tagen, Mike; Singh, Jatinder; Sarkar, Indrani; Mueller, Lars; Dokainish, Hatem; Shapiro, Geoffrey; Burris, Howard Journal: Oncologist Issue: Volume 25:Number 10(2020) Page Start: 833 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CTNI-23. PRELIMINARY SAFETY AND PHARMACOKINETICS DATA FOR A PHASE 1B TRIAL OF TELAGLENASTAT IN COMBINATION WITH RADIATION THERAPY AND TEMOZOLOMIDE IN PATIENTS WITH IDH-MUTANT GRADE 2/3 ASTROCYTOMA (NCI-10218). (14th November 2022) Authors: Kizilbash, Sani; Piccioni, David; Sahebjam, Solmaz; Villano, John; Jaeckle, Kurt; Welch, Mary; Kong, Xiao-Tang; Holdhoff, Matthias; Lammers, Anita; Remick, Adam; Reid, Joel; Allred, Jacob; Port, John; Lanza, Ian; McBrayer, Samuel; Kunos, Charles; Shapiro, Geoffrey; Adjei, Alex Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗